KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Imax (IMAX) Asset Writedowns and Impairment (2016 - 2025)

Imax's Asset Writedowns and Impairment history spans 12 years, with the latest figure at $2.3 million for Q2 2024.

  • For Q2 2024, Asset Writedowns and Impairment rose 1247.06% year-over-year to $2.3 million; the TTM value through Jun 2024 reached $3.7 million, up 88.44%, while the annual FY2023 figure was $1.8 million, 75.49% down from the prior year.
  • Asset Writedowns and Impairment for Q2 2024 was $2.3 million at Imax, up from $109000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $2.4 million in Q4 2020 and bottomed at -$4.7 million in Q4 2021.
  • The 5-year median for Asset Writedowns and Impairment is $300000.0 (2021), against an average of $322466.7.
  • The largest annual shift saw Asset Writedowns and Impairment tumbled 292.45% in 2021 before it soared 2433.33% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $2.4 million in 2020, then crashed by 292.45% to -$4.7 million in 2021, then skyrocketed by 131.17% to $1.5 million in 2022, then grew by 21.58% to $1.8 million in 2023, then increased by 28.22% to $2.3 million in 2024.
  • Per Business Quant, the three most recent readings for IMAX's Asset Writedowns and Impairment are $2.3 million (Q2 2024), $109000.0 (Q1 2024), and $1.8 million (Q4 2023).